Wednesday, July 12, 2017 1:04:10 PM
I jumped the gun saying five Iowa counties were ready to go, so yet another LMLYP/yakyakyak/rosesarefree/geneanddean correction.
One of my many blunders a few years back (besides posting we are worth $3 at the time) was saying a buyer could take advantage of PCHM"s tax loss carry forwards. The New York Times has nothing on me when it comes to retractions.
I am a square peg. A nerd. A geek. I am square. So let me use round numbers. These are not estimates. These are made up round sales numbers.
2016 $4 million up 25%, 2017 $5 million up 20%, 2018 $6 million up 17%. Earnings per share will accelerate more rapidly. Cash position grows leading to higher dividends. Sales rates could go back over 20/25% from a much higher base after that.
Someone should look at the PMD's and OSUR's of the world or even the LH's and DGX's and do a valuation comparison.
Al Franken. Deep Thoughts.
PCHM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM